Borrow to exercise. Lower cost than non-recourse, but full personal liability if the company fails.
Recourse financing covers the cost of exercising options using borrowed capital. Traditional institutional lenders and commercial banks don't underwrite loans secured solely by illiquid private company stock: the collateral is impossible to value reliably. So recourse financing typically takes one of three forms: a HELOC secured by real estate equity, a margin loan against an existing public brokerage account, or an unsecured personal consumer loan. The borrower uses the loan proceeds to pay the strike price and tax withholding, then repays the loan with interest over time.
The primary advantage of recourse financing is lower cost of capital compared to non-recourse structures. HELOCs and portfolio margin loans offer rates tied to SOFR or the Prime rate, typically 6–8%. Unsecured personal consumer loans carry much higher rates, often exceeding 20% annually, and generally cap borrowing limits at around $50,000, making them impractical for large executive option exercises. Unlike non-recourse loans, recourse financing requires mandatory monthly cash interest payments, actively draining your liquid cash flow throughout the pre-IPO waiting period, long before any liquidity event.
The risk profile of recourse financing is stacked heavily against the borrower. If using a margin loan, a broader public market decline can force immediate liquidation of pledged assets via margin call. Most critically, if the startup fails, the borrower remains legally bound to repay the entire debt incurred for shares that are now worthless, a scenario that can easily force an individual into personal bankruptcy. The lender possesses the legal right to seize not just the pledged collateral but any personal assets needed to cure the deficiency if collateral is insufficient.
Generally no. Traditional banks and institutional lenders don't underwrite loans secured solely by illiquid, unproven private company stock. Recourse financing for equity exercise typically uses real estate equity (HELOC), existing public brokerage accounts (margin), or unsecured personal credit, not the private shares themselves.
If the company fails, you still owe the full HELOC balance, secured by your home. You would need to repay the loan, potentially by selling your house, for shares that are now worthless. Unlike non-recourse financing, there is no scenario where the lender simply absorbs the loss.
Recourse loans cost less (6–8% vs. 7–12% + 5–30% carry for non-recourse) and let you keep 100% of the upside. But they require monthly cash payments and leave you personally liable for the full debt if the company fails. Non-recourse financing costs more overall but provides complete asset protection: if the company fails, the lender absorbs the loss, not you.
These providers operate in the Recourse Financing space. StrikeRates does not endorse or recommend any provider. Review each independently.
Use the scenario modeler to see how Recourse Financing mechanics play out with your specific grant, or join the waitlist for deeper, personalized equity intelligence.